Cardlytics Proceeds Profits Contraction Among Deteriorating Business Economics (NASDAQ: CDLX)

.Financial writer highly recommends selling Cardlytics, Inc. due to declining system economics, income challenges, as well as damaging economic patterns. Click for this CDLX update.